ElectromedELMD +2.38%91 Net Margin % is 16.17% as of Mar. 2026, which is 112% above its 10-year median of 7.62. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.15 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Electromed ranks better than 81.27% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Electromed's Net Income for the
three
months ended in Mar. 2026 was $3.00 Mil. Electromed's Revenue for the
three
months ended in Mar. 2026 was $18.58 Mil. Therefore, Electromed's net margin for the quarter that ended in Mar. 2026 was 16.17%.
The historical rank and industry rank for Electromed's Net Margin % or its related term are showing as below:
ELMD'
s Net Margin % Range Over the Past 10 Years
Min: 5.53 Med: 7.62 Max: 14.08
Current: 14.08
ELMD's Net Margin % is ranked better than 81.27% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs ELMD: 14.08
Electromed (AMEX:ELMD) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Electromed Net Margin % Related Terms
Electromed Net Margin % Historical Data
* Premium members only.
The historical data trend for Electromed's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Electromed's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Electromed Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Net Margin % distribution charts can be found below:
* The bar in red indicates where Electromed's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Electromed (ELMD) has a Net Margin % of 16.17% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Electromed and its competitors. This is 112% above median its historical median of 7.62. Over the past decade, Electromed's Net Margin % has ranged from 5.53 to 14.08. According to the industry distribution chart, Electromed ranks #153 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 18.7%.
Is Electromed's Net Margin % too high?
Electromed's current Net Margin % of 16.17% is 112% above median its 10-year median of 7.62. Over the past 10 years, this metric has ranged from a low of 5.53 to a high of 14.08. The Medical Devices & Instruments industry median Net Margin % is 2.07. Electromed's value of 16.17% is 681.2% above this industry median. Based on the distribution chart, Electromed ranks #153 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Net Margin % compare to MASS and SI?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #153 out of 817 companies for Net Margin %. This places Electromed in the top 19% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Electromed's value of 16.17% is 681.2% above this benchmark. Historically, Electromed's own Net Margin % has ranged from 5.53 to 14.08 over the past decade. While the company's 10-year median is 7.62 vs. the industry median of 2.07, Electromed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Electromed's current Net Margin % of 16.17% is 681.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Electromed and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Electromed's current Net Margin % is 16.17%, which is 112% above median its own 10-year median of 7.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.15, compared to a current price of $40.05 — trading 59.2% above its estimated fair value. The current Net Margin % is 16.17%, which is 112% above median its 10-year median of 7.62 and 681.2% above the Medical Devices & Instruments industry median of 2.07. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Electromed (ELMD), the current Net Margin % is 16.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Electromed (ELMD) Overvalued in 2026?
Based on GuruFocus' analysis, Electromed stock appears to be overvalued.
The current stock price of $40.05 is trading 59.2% above its estimated GF Value™ of $25.15.
GuruFocus considers Electromed to be Significantly Overvalued.
Key valuation signals for ELMD:
Net Margin %: 16.17% (112% above median its 10-year median of 7.62)
GF Value™: $25.15 vs. price of $40.05 (59.2% above fair value)
Industry Position: 681.2% above the Medical Devices & Instruments median (#153 of 817)
No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score
Get the complete analysis for ELMD
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELMD has been successfully added to your 
